Drug Type T-lymphocyte cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism T lymphocyte replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myositis, Inclusion Body | Discovery | United States | - | |
Myositis, Inclusion Body | Discovery | United States | - |